Works matching IS 0741238X AND DT 2024 AND VI 41 AND IP 8


Results: 29
    1
    2

    Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 8, p. 3299, doi. 10.1007/s12325-024-02936-4
    By:
    • Patel, Jyoti;
    • Meng, Jie;
    • Le, Hoa;
    • Tanaka, Yoko;
    • Phani, Sudarshan;
    • Salas, Maribel;
    • Wu, Chuntao;
    • Sternberg, David;
    • Esker, Stephen;
    • Anderson, Jeffrey P.;
    • Crowley, Aaron;
    • Zhou, Summera Q.;
    • Lieb, Camryn;
    • Sun, Haiyan;
    • Doan, Quan V.;
    • Santhanagopal, Anu;
    • Reckamp, Karen L.
    Publication type:
    Article
    3
    6

    Treatment Strategies for Filamentous Fungi Keratitis.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 8, p. 3316, doi. 10.1007/s12325-024-02929-3
    By:
    • Storr, Julia;
    • Zapp, Daniel;
    • Bleidißel, Nathalie;
    • Mayer, Christian S.;
    • Maier, Mathias M.;
    • Rothe, Kathrin
    Publication type:
    Article
    7
    8
    9
    10
    11

    Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

    Published in:
    Advances in Therapy, 2024, v. 41, n. 8, p. 3039, doi. 10.1007/s12325-024-02918-6
    By:
    • De Santis, Maria;
    • Breijo, Sara Martínez;
    • Robinson, Paul;
    • Capone, Camille;
    • Pascoe, Katie;
    • Van Sanden, Suzy;
    • Hashim, Mahmoud;
    • Trevisan, Marco;
    • Daly, Caitlin;
    • Reitsma, Friso;
    • van Beekhuizen, Sophie;
    • Ruan, Haoyao;
    • Heeg, Bart;
    • Verzoni, Elena
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 8, p. 3059, doi. 10.1007/s12325-024-02902-0
    By:
    • Gudesblatt, Mark;
    • Bumstead, Barbara;
    • Buhse, Marijean;
    • Zarif, Myassar;
    • Morrow, Sarah A.;
    • Nicholas, Jacqueline A.;
    • Hancock, Laura M.;
    • Wilken, Jeffrey;
    • Weller, Joanna;
    • Scott, Nicole;
    • Gocke, Anne;
    • Lewin, James B.;
    • Kaczmarek, Olivia;
    • Mendoza, Jason P.;
    • Golan, Daniel
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    APPaRENT 3: Asthma Patients' and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 8, p. 3089, doi. 10.1007/s12325-024-02900-2
    By:
    • Aggarwal, Bhumika;
    • Al-Moamary, Mohamed;
    • Allehebi, Riyad;
    • Alzaabi, Ashraf;
    • Al-Ahmad, Mona;
    • Amin, Muhammad;
    • Damayanti, Triya;
    • Van Tho, Nguyen;
    • Quyen, Pham Thi Le;
    • Sriprasart, Thitiwat;
    • Poachanukoon, Orapan;
    • Yu-Lin, Andrea Ban;
    • Ismail, Ahmad Izuanuddin;
    • Limpin, Maria Encarnita B.;
    • Koenig, Steven;
    • Levy, Gur;
    • Phansalkar, Abhay;
    • Rafih, Farouz;
    • Silvey, Mark;
    • Miriams, Laura
    Publication type:
    Article